The current gold standard to assess viral neutralization by CP is the plaque reduction neutralization test (PRNT), which measures the ability of neutralizing antibodies to prevent infection in vitro calculated as a reduction in the formation of plaques [14]. The gene discussed is CP; the disease is infection.